- Alterations in the endocannabinoid system in the rat valproic acid model of autism
- Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
- Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders
- Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders
- Deficient Social and Play Behavior in Juvenile and Adult Rats after Neonatal Cortical Lesion- Effects of Chronic Pubertal Cannabinoid Treatment
- Endocannabinoid System as Novel Therapeutic Target for Autism Treatment
- Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
- Species differences in cannabinoid receptor 2 (CNR2 gene)- identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
- Use of dronabinol (delta-9-THC) in autism- A prospective single-case-study with an early infantile autistic child
- Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.